Bratton Capital Management, L.P.

Holdings History for Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)

Symbol: AQST on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	100%	0%	$63,378,789	9,810,958	0		$6.46	Q4 2025
30 Sep 2025	100%	0%	$54,843,255	9,810,958	0		$5.59	Q3 2025
30 Jun 2025	100%	0%	$32,474,271	9,810,958	0		$3.31	Q2 2025
31 Mar 2025	100%	0%	$28,451,778	9,810,958	0		$2.90	Q1 2025
31 Dec 2024	100%	0%	$34,927,010	9,810,958	0		$3.56	Q4 2024
30 Sep 2024	100%	0%	$48,858,571	9,810,958	0		$4.98	Q3 2024
30 Jun 2024	100%	0%	$25,508,491	9,810,958	0		$2.60	Q2 2024
31 Mar 2024	100%	0%	$41,794,681	9,810,958	0		$4.26	Q1 2024
31 Dec 2023	100%	0%	$19,818,135	9,810,958	0		$2.02	Q4 2023
30 Sep 2023		0%	$1,501,766	9,810,958	0		$0.15 ^*	Q3 2023
30 Jun 2023	100%	0%	$16,188,081	9,810,958	0		$1.65	Q2 2023
31 Mar 2023	100%	0%	$11,184,492	9,810,958	0		$1.14	Q1 2023
31 Dec 2022	100%	0%	$8,849,484	9,810,958	0		$0.90	Q4 2022
30 Sep 2022	100%	0%	$11,479,000	9,810,958	0		$1.17	Q3 2022
30 Jun 2022	100%	0%	$6,279,000	9,810,958	0		$0.64	Q2 2022
31 Mar 2022	100%	0%	$25,607,000	9,810,958	0		$2.61	Q1 2022
31 Dec 2021	100%	0%	$38,165,000	9,810,958	0		$3.89	Q4 2021
30 Sep 2021	100%	0%	$42,776,000	9,810,958	0		$4.36	Q3 2021
30 Jun 2021	100%	0%	$38,950,000	9,810,958	0		$3.97	Q2 2021
31 Mar 2021	100%	-17%	$51,017,000	9,810,958	-1,692,336	-15%	$5.20	Q1 2021
31 Dec 2020	100%	0%	$61,543,000	11,503,294	0		$5.35	Q4 2020
30 Sep 2020	78%	0%	$55,848,000	11,503,294	0		$4.85	Q3 2020
30 Jun 2020	84%	0%	$55,906,000	11,503,294	0		$4.86	Q2 2020
31 Mar 2020	60%	0%	$25,192,000	11,503,294	0		$2.19	Q1 2020
31 Dec 2019	80%	0%	$66,949,000	11,503,294	0		$5.82	Q4 2019
30 Sep 2019	71%	0%	$36,580,000	11,503,294	0		$3.18	Q3 2019
30 Jun 2019	71%	0%	$48,313,000	11,503,294	0		$4.20	Q2 2019
31 Mar 2019	78%	0%	$79,487,000	11,503,294	0		$6.91	Q1 2019
31 Dec 2018	76%	0%	$72,471,000	11,503,294	0		$6.30	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.